2432.HK 9885.HK

Robot manufacturer Shenzhen Dobot Corp. Ltd. (2432.HK) on Tuesday announced a strategic collaboration with YSB Inc. (9885.HK) to jointly develop robots for pharmaceutical applications. The partnership will see Dobot spearhead product development, as well as post-sales maintenance. YSB will validate application scenarios, facilitate operational integration, and lead marketing and sales efforts for the co-developed robots.

Both parties have already finalized a plan for their first project, including completion of a feasibility study, technical route research and judgement, exchange of technical solutions, and selection of suitable deployment environment, and have begun to build a test platform.

Founded in 2015, Dobot develops and manufactures collaborative robots, with a portfolio of over 20 products. YSB, established the same year, provides digital and smart solutions for independent pharmacies, drugstore chains, and primary care institutions.

Shares of Dobot opened up 1.7% at HK$58.90 on Wednesday and continued to rise during the session to close up 7.4% at the midday break. YSB shares opened up 7% at HK$10.76, but gave back most of the gains to close up 0.8% by the midday break.

By Lau Chi Hang

To subscribe to Bamboo Works weekly free newsletter, click here

Recent Articles

Qudian abandons last mile delivery

Qudian: A slow-motion privatization?

The company said it is contemplating winding down its last-mile delivery service after stiff competition caused its revenue to plunge in the first quarter Key Takeaways: Qudian’s revenue fell by…
Yeahka secures bridgehead in U.S. payments market

Yeahka secures bridgehead in U.S. payments market

The Chinese fintech has cleared one of many regulatory hurdles to enter the U.S. digital payments business after gaining a state-level operating license Key Takeaways: After getting U.S. federal clearance,…
Sante makes infant nutritional products

Sainte Nutritional nurtures Hong Kong IPO

The Qingdao-based maker of food for special medical purposes is challenging international firms that still dominate the China market but could face tariff uncertainties Key Takeaways: Sainte Nutritional has filed…